CLINICAL_TRIALS
research
· 2026-04-17
Clinical Trial Update: Study of Patient With Frequent COPD Exacerbations
Summary
AstraZeneca-sponsored COPD trial (NCT07221981) is currently active but not recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Status: ACTIVE_NOT_RECRUITING